{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:10Z","timestamp":1781650810930,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05871-0","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:56:00Z","timestamp":1777028160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic and clinical impact of diagnostic sensitivity for the use of insertable cardiac monitors to detect atrial fibrillation in cryptogenic stroke patients in the United Kingdom"],"prefix":"10.1186","volume":"26","author":[{"given":"Klaus K.","family":"Witte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hsuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Rosemas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Villinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"1","key":"5871_CR1","first-page":"467","volume":"5","author":"S Bordignon","year":"2012","unstructured":"Bordignon S, Chiara Corti M, Bilato C. Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality. J Atr fibrillation. 2012;5(1):467.","journal-title":"J Atr fibrillation"},{"issue":"8","key":"5871_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983\u20138.","journal-title":"Stroke"},{"issue":"3","key":"5871_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","volume":"47","author":"H Kamel","year":"2016","unstructured":"Kamel H, Okin PM, Elkind MS, Iadecola C. Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke. 2016;47(3):895\u2013900.","journal-title":"Stroke"},{"issue":"2","key":"5871_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med. 2012;366(2):120\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"5871_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.amjcard.2012.03.021","volume":"110","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Corbucci G, Padeletti L. Usefulness of Continuous Electrocardiographic Monitoring for Atrial Fibrillation. Am J Cardiol. 2012;110(2):270\u20136.","journal-title":"Am J Cardiol"},{"issue":"2","key":"5871_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.15420\/AER.2016.17.2","volume":"5","author":"A Galli","year":"2016","unstructured":"Galli A, Ambrosini F, Lombardi F. Holter Monitoring and Loop Recorders: From Research to Clinical Practice. Arrhythmia Electrophysiol Rev. 2016;5(2):136\u201343.","journal-title":"Arrhythmia Electrophysiol Rev"},{"issue":"7","key":"5871_CR7","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke"},{"issue":"10","key":"5871_CR8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/europace\/eus305","volume":"14","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. EP Europace. 2012;14(10):1385\u2013413.","journal-title":"EP Europace"},{"issue":"11","key":"5871_CR9","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/hs1101.098524","volume":"32","author":"AJ Grau","year":"2001","unstructured":"Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank. Stroke. 2001;32(11):2559\u201366.","journal-title":"Stroke"},{"issue":"1","key":"5871_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams","year":"1993","unstructured":"Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"1","key":"5871_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/17434440.2018.1557046","volume":"16","author":"R Sakhi","year":"2019","unstructured":"Sakhi R, Theuns DAMJ, Szili-Torok T, Yap S-C. Insertable cardiac monitors: current indications and devices. Expert Rev Med Dev. 2019;16(1):45\u201355.","journal-title":"Expert Rev Med Dev"},{"issue":"26","key":"5871_CR12","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic Stroke and Underlying Atrial Fibrillation. N Engl J Med. 2014;370(26):2478\u201386.","journal-title":"N Engl J Med"},{"issue":"3","key":"5871_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"5","key":"5871_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"key":"5871_CR15","unstructured":"(NICE) NIfHaCE. Atrial fibrillation: diagnosis and management. NICE guideline NG196. 2021."},{"issue":"5","key":"5871_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24050","volume":"24","author":"SJ Edwards","year":"2020","unstructured":"Edwards SJ, Wakefield V, Jhita T, Kew K, Cain P, Marceniuk G. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation. Health Technol Assess. 2020;24(5):1\u2013184.","journal-title":"Health Technol Assess"},{"issue":"2","key":"5871_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/cer-2020-0224","volume":"10","author":"LM Sawyer","year":"2021","unstructured":"Sawyer LM, Witte KK, Reynolds MR, Mittal S, Grimsey Jones FW, Rosemas SC, et al. Cost\u2013effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. J Comp Eff Res. 2021;10(2):127\u201341.","journal-title":"J Comp Eff Res"},{"issue":"12","key":"5871_CR18","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1161\/STROKEAHA.112.667204","volume":"43","author":"R Luengo-Fernandez","year":"2012","unstructured":"Luengo-Fernandez R, Gray AM, Rothwell PM, Oxford Vascular S. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke. 2012;43(12):3343\u201351.","journal-title":"Stroke"},{"issue":"28","key":"5871_CR19","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/eurheartj\/ehu006","volume":"35","author":"P Dorian","year":"2014","unstructured":"Dorian P, Kongnakorn T, Phatak H, Rublee DA, Kuznik A, Lanitis T, et al. Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Eur Heart J. 2014;35(28):1897\u2013906.","journal-title":"Eur Heart J"},{"issue":"2","key":"5871_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clinthera.2013.12.011","volume":"36","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Kongnakorn T, Phatak H, Kuznik A, Lanitis T, Liu LZ, et al. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation. Clin Ther. 2014;36(2):192\u2013e21020.","journal-title":"Clin Ther"},{"key":"5871_CR21","unstructured":"(NICE) NIfHaCE. Guide to the methods of technology appraisal 2012. NICE process and methods PMG9. 2013."},{"key":"5871_CR22","unstructured":"(NICE) NIfHaCE. NICE health technology evaluations: the manual. NICE process and methods PMG36. 2023."},{"issue":"1","key":"5871_CR23","doi-asserted-by":"publisher","first-page":"e001037","DOI":"10.1136\/openhrt-2019-001037","volume":"6","author":"CI Rinciog","year":"2019","unstructured":"Rinciog CI, Sawyer LM, Diamantopoulos A, Elkind MSV, Reynolds M, Tsintzos SI, et al. Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK. Open Heart. 2019;6(1):e001037\u2013e.","journal-title":"Open Heart"},{"issue":"1","key":"5871_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation. J Am Coll Cardiol. 2019;74(1):104\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"FI3","key":"5871_CR25","doi-asserted-by":"publisher","first-page":"f321","DOI":"10.1093\/europace\/eux272","volume":"20","author":"H Purerfellner","year":"2018","unstructured":"Purerfellner H, Sanders P, Sarkar S, Reisfeld E, Reiland J, Koehler J, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. 2018;20(FI3):f321\u20138.","journal-title":"Europace"},{"issue":"16","key":"5871_CR26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BSP, et al. Selecting Patients With Atrial Fibrillation for Anticoagulation. Circulation. 2004;110(16):2287\u201392.","journal-title":"Circulation"},{"issue":"6","key":"5871_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1474-4422(12)70092-3","volume":"11","author":"JD Easton","year":"2012","unstructured":"Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, et al. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol. 2012;11(6):503\u201311.","journal-title":"Lancet Neurol"},{"issue":"9","key":"5871_CR28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/jnnp.2008.170456","volume":"80","author":"KM Mohan","year":"2009","unstructured":"Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CDA, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2009;80(9):1012\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"5871_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(12)70017-0","volume":"11","author":"H-C Diener","year":"2012","unstructured":"Diener H-C, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GYH, et al. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol. 2012;11(3):225\u201331.","journal-title":"Lancet Neurol"},{"issue":"12","key":"5871_CR30","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1161\/STROKEAHA.112.673558","volume":"43","author":"G Ntaios","year":"2012","unstructured":"Ntaios G, Papavasileiou V, Diener H-C, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials. Stroke. 2012;43(12):3298\u2013304.","journal-title":"Stroke"},{"issue":"4","key":"5871_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1212\/WNL.48.4.891","volume":"48","author":"HS Jorgensen","year":"1997","unstructured":"Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology. 1997;48(4):891\u20135.","journal-title":"Neurology"},{"issue":"3","key":"5871_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/01.STR.0000116183.50167.D9","volume":"35","author":"K Hardie","year":"2004","unstructured":"Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35(3):731\u20135.","journal-title":"Stroke"},{"issue":"5","key":"5871_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1747-4949.2012.00812.x","volume":"8","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Yiin GS, Gray AM, Rothwell PM. Population-based study of acute- and long-term care costs after stroke in patients with AF. Int J Stroke. 2013;8(5):308\u201314.","journal-title":"Int J Stroke"},{"issue":"8","key":"5871_CR34","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","volume":"34","author":"MJ Ariesen","year":"2003","unstructured":"Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk Factors for Intracerebral Hemorrhage in the General Population. Stroke. 2003;34(8):2060\u20135.","journal-title":"Stroke"},{"issue":"12","key":"5871_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2009;361(12):1139\u201351.","journal-title":"N Engl J Med"},{"issue":"11","key":"5871_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"4","key":"5871_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","volume":"11","author":"GJ Hankey","year":"2012","unstructured":"Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012;11(4):315\u201322.","journal-title":"Lancet Neurol"},{"key":"5871_CR38","doi-asserted-by":"crossref","unstructured":"Claassen DO, Kazemi N, Zubkov AY, Wijdicks EFM, Rabinstein AA. Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage. Arch Neurol. 2008;65(10).","DOI":"10.1001\/archneur.65.10.1313"},{"issue":"6","key":"5871_CR39","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ahj.2009.03.022","volume":"157","author":"SV Sorensen","year":"2009","unstructured":"Sorensen SV, Dewilde S, Singer DE, Goldhaber SZ, Monz BU, Plumb JM. Cost-effectiveness of warfarin: trial versus real-world stroke prevention in atrial fibrillation. Am Heart J. 2009;157(6):1064\u201373.","journal-title":"Am Heart J"},{"issue":"9","key":"5871_CR40","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","volume":"364","author":"SJ Connolly","year":"2011","unstructured":"Connolly SJ, Eikelboom J, Joyner C, Diener H-C, Hart R, Golitsyn S, et al. Apixaban in Patients with Atrial Fibrillation. N Engl J Med. 2011;364(9):806\u201317.","journal-title":"N Engl J Med"},{"issue":"22","key":"5871_CR41","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"10","key":"5871_CR42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"key":"5871_CR43","first-page":"93","volume":"8","author":"A Tawfik","year":"2016","unstructured":"Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, et al. Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation. Clin pharmacology: Adv Appl. 2016;8:93\u2013107.","journal-title":"Clin pharmacology: Adv Appl"},{"key":"5871_CR44","unstructured":"Office for National S. Deaths registered in England and Wales: 2019. 2020."},{"issue":"9","key":"5871_CR45","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/hs0901.094253","volume":"32","author":"H Br\u00f8nnum-Hansen","year":"2001","unstructured":"Br\u00f8nnum-Hansen H, Davidsen M, Thorvaldsen P, Danish MSG. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131\u20136.","journal-title":"Stroke"},{"key":"5871_CR46","doi-asserted-by":"crossref","unstructured":"Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008;26(4):381\u20137.","DOI":"10.1159\/000151678"},{"issue":"6","key":"5871_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.amjcard.2015.06.012","volume":"116","author":"WC Choe","year":"2015","unstructured":"Choe WC, Passman RS, Brachmann J, Morillo CA, Sanna T, Bernstein RA, et al. A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial). Am J Cardiol. 2015;116(6):889\u201393.","journal-title":"Am J Cardiol"},{"issue":"5","key":"5871_CR48","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.4022\/jafib.2387","volume":"13","author":"G Aggarwal","year":"2021","unstructured":"Aggarwal G, Aggarwal S, Alla V, Narasimhan B, Ryu K, Jeffery C, et al. Subcutaneouscardiac Rhythm Monitors: A Comprehensive Review. J Atr fibrillation. 2021;13(5):2387.","journal-title":"J Atr fibrillation"},{"issue":"6","key":"5871_CR49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0272989X11401031","volume":"31","author":"PW Sullivan","year":"2011","unstructured":"Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D Scores for the United Kingdom. Med Decis Making. 2011;31(6):800\u20134.","journal-title":"Med Decis Making"},{"issue":"18","key":"5871_CR50","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/WNL.0b013e3182a9f45f","volume":"81","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Gray AM, Bull L, Welch S, Cuthbertson F, Rothwell PM, et al. Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study. Neurology. 2013;81(18):1588\u201395.","journal-title":"Neurology"},{"issue":"5","key":"5871_CR51","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","volume":"13","author":"R Ara","year":"2010","unstructured":"Ara R, Brazier JE. Populating an economic model with health state utility values: moving toward better practice. Value Health. 2010;13(5):509\u201318.","journal-title":"Value Health"},{"issue":"3","key":"5871_CR52","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/1747493015620803","volume":"11","author":"A Diamantopoulos","year":"2016","unstructured":"Diamantopoulos A, Sawyer LM, Lip GYH, Witte KK, Reynolds MR, Fauchier L, et al. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. Int J Stroke. 2016;11(3):302\u201312.","journal-title":"Int J Stroke"},{"key":"5871_CR53","unstructured":"Department of H. NHS reference costs 2022\u20132023. Department of Health2023."},{"key":"5871_CR54","unstructured":"Jones KC, Weatherly H, Birch S, Castelli A, Chalkley M, Dargan A et al. Unit Costs of Health and Social Care 2023 Manual. 2024."},{"issue":"2","key":"5871_CR55","doi-asserted-by":"publisher","first-page":"e27720","DOI":"10.2196\/27720","volume":"5","author":"A Seiler","year":"2021","unstructured":"Seiler A, Biundo E, Di Bacco M, Rosemas S, Nicolle E, Lanctin D, et al. Clinic Time Required for Remote and In-Person Management of Patients With Cardiac Devices: Time and Motion Workflow Evaluation. JMIR Cardio. 2021;5(2):e27720\u2013e.","journal-title":"JMIR Cardio"},{"key":"5871_CR56","unstructured":"(NICE). NIfHaCE. Apixaban Medical forms. British National Formulary2024."},{"key":"5871_CR57","unstructured":"(NICE) NIfHaCE. Dabigatran etexilate Medical forms. British National Formulary2024."},{"key":"5871_CR58","unstructured":"(NICE). NIfHaCE. Edoxaban Medical forms. British National Formulary2024."},{"key":"5871_CR59","unstructured":"(NICE). NIfHaCE. Rivaroxaban Medical forms. British National Formulary2024."},{"key":"5871_CR60","unstructured":"(NICE). NIfHaCE. Aspirin Medicinal forms. British National Formulary2024."},{"key":"5871_CR61","unstructured":"(NICE) NIfHaCE. Warfarin sodium Medicinal forms. British National Formulary2024."},{"issue":"3","key":"5871_CR62","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/archinte.1994.00420030084008","volume":"154","author":"J Hirsh","year":"1994","unstructured":"Hirsh J. The International Normalized Ratio. Arch Intern Med. 1994;154(3):282.","journal-title":"Arch Intern Med"},{"issue":"12","key":"5871_CR63","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/jce.13089","volume":"27","author":"G N\u00d6Lker","year":"2016","unstructured":"N\u00d6Lker G, Mayer J, Boldt LH, Seidl K, Van Driel V, Massa T, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophys. 2016;27(12):1403\u201310.","journal-title":"J Cardiovasc Electrophys"},{"issue":"4","key":"5871_CR64","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jce.15397","volume":"33","author":"RS Gardner","year":"2022","unstructured":"Gardner RS, Quartieri F, Betts TR, Afzal MR, Manyam H, Badie N, et al. Reducing the electrogram review burden imposed by insertable cardiac monitors. J Cardiovasc Electrophys. 2022;33(4):741\u201350.","journal-title":"J Cardiovasc Electrophys"},{"key":"5871_CR65","volume-title":"Retrospective analysis of Confirm Rx SharpSense Technology using Real-World Data from the SMART Registry","year":"2019","unstructured":"Quartieri FCFCL, et al. editors. Retrospective analysis of Confirm Rx SharpSense Technology using Real-World Data from the SMART Registry. Bangkok: Asia Pacific Heart Rhythm Society (APHRS); 2019."},{"issue":"8","key":"5871_CR66","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.119.025169","volume":"50","author":"G Tsivgoulis","year":"2019","unstructured":"Tsivgoulis G, Katsanos AH, Grory BM, Kohrmann M, Ricci BA, Tsioufis K, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. 2019;50(8):2175\u201380.","journal-title":"Stroke"},{"issue":"5","key":"5871_CR67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cvdhj.2022.07.071","volume":"3","author":"F Quartieri","year":"2022","unstructured":"Quartieri F, Marina-Breysse M, Pollastrelli A, Paini I, Lizcano C, Lillo-Castellano JM, et al. Artificial intelligence augments detection accuracy of cardiac insertable cardiac monitors: Results from a pilot prospective observational study. Cardiovasc Digit Health J. 2022;3(5):201\u201311.","journal-title":"Cardiovasc Digit Health J"},{"key":"5871_CR68","doi-asserted-by":"crossref","unstructured":"Crespin E, Rosier A, Ibnouhsein I, Gozlan A, Lazarus A, Laurent G et al. Improved diagnostic performance of insertable cardiac monitors by an artificial intelligence-based algorithm. Europace. 2023;26(1).","DOI":"10.1093\/europace\/euad375"},{"key":"5871_CR69","doi-asserted-by":"publisher","first-page":"e12895","DOI":"10.1590\/1414-431x2023e12895","volume":"56","author":"AC Goulart","year":"2023","unstructured":"Goulart AC, Varella AC, Tunes G, Alencar AP, Santos IS, Romagnolli C, et al. Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study. Braz J Med Biol Res. 2023;56:e12895.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"5871_CR70","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/23969873241300888","volume":"10","author":"A Alvarado-Bolanos","year":"2025","unstructured":"Alvarado-Bolanos A, Ayan D, Lodol F, Khaw AV, Mai LM, Mandzia JL, et al. Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection. Eur Stroke J. 2025;10(2):461\u20138.","journal-title":"Eur Stroke J"},{"issue":"7","key":"5871_CR71","doi-asserted-by":"publisher","first-page":"e006274","DOI":"10.1161\/CIRCEP.118.006274","volume":"11","author":"JS Steinberg","year":"2018","unstructured":"Steinberg JS, O\u2019Connell H, Li S, Ziegler PD. Thirty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship With Subsequent Arrhythmia Patterns: Analysis of a Large Prospective Device Database. Circulation Arrhythmia Electrophysiol. 2018;11(7):e006274\u2013e.","journal-title":"Circulation Arrhythmia Electrophysiol"},{"issue":"1","key":"5871_CR72","doi-asserted-by":"publisher","first-page":"e003333","DOI":"10.1161\/CIRCEP.115.003333","volume":"9","author":"J Brachmann","year":"2016","unstructured":"Brachmann J, Morillo CA, Sanna T, Di Lazzaro V, Diener HC, Bernstein RA, et al. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial. Circ Arrhythm Electrophysiol. 2016;9(1):e003333.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"5871_CR73","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.hrthm.2016.03.005","volume":"13","author":"P Sanders","year":"2016","unstructured":"Sanders P, P\u00fcrerfellner H, Pokushalov E, Sarkar S, Di Bacco M, Maus B, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: Results from the Reveal LINQ Usability Study. Heart Rhythm. 2016;13(7):1425\u201330.","journal-title":"Heart Rhythm"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05871-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:40:24Z","timestamp":1781649624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5871"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05871-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol for the CRYSTAL AF study was approved by all relevant institutional review boards or ethics committees, and all patients provided written informed consent before randomization. The CRYSTAL-AF study was conducted in accordance with Good Clinical Practice and ISO-14155 as guidance and in compliance with the Declaration of Helsinki and the laws and regulations of the participating countries. A list of all Institutional Review Boards (IRBs) \/ ethics committees that approved the CRYSTAL AF study has been provided below and can be found in the supplemental material (pages 236\u2013239) of the original publication[\n                      \n                      ].Baylor Research Institute IRB; Comite d\u2019Ethique de la Recherche en Sante Chez l-h IRB; Forsyth Medical Center IRB; Hamilton Health Sciences\/McMaster Health Sciences IRB; Mercy Medical Center IRB; New York Presbyterian Hospital Weill Medical College IRB; North Mississippi Health Services IRB; Northwestern University IRB; Peace Health IRB; Riverside Methodist Hospital\/Grady Memorial IRB; Rush University Medical Center IRB; Saint Luke\u2019s Hospital IRB; Sterling IRB; Western Institutional Review Board; Regionshuset Viborg, Sundnedssekkreterteiet De Videnskabsetisl\u00e6 Komiteer For Region Midtjylland; Faculteit Geneeskunde, Commissie voor medische ethiek\/klinisch onderzoek; Committee d\u2019\u00e9thique m\u00e9dicale des Cliniques Universitaires UCL Mont-Godinne; UZ Antwerpen, Komite voor Medische Ethiek; Ethikkommission fuer das Bundesland Niederoesterreich am Sitz des Amtes der NO Landesregierung Abteilung Sanitaetsund Krankenanstaltenrecht; Medizinische Universitaet Graz, Ethikkomission; Ethik-Kommission, Aerztekammer Westfalen-Lippe; Freiburger ethik-kommission International; Comit\u00e9 de protection des Personnes Sud-Ouest et Outre Mer III; Ethics Committee Universita cattolica del Sacro Cuore \u201cAgostino Gemelli\u201c; Comitato Ethico; Azienda Unit\u00e0 Sanitaria Locale 9 Grosseto; Azienda Ospedaliera Bolognini Seriate, Independant Ethics Committee; Ethics Committee, Errikos Dynan Hospital; Ethik-Kommission de Ned. Fakultaet der RUB; Regionala Etikprovningsnamneden; Comite etico de investigacion clinica del hospital universitario Peurta de Hierro Majadahonda; Ethica komisia Bratislavsk\u00e9ho samospravneho kraja Sabinovska; Universitaetsklinikum Essen, Ethik-Komission; Medische Ethische Toetsingscommissie Maaslandziekenhuis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KW has received unconditional research funding from Medtronic to the University of Leeds for a Ph.D. Fellowship program and consultancy or speaker fees from Medtronic, Novartis, AstraZeneca, Pfizer, Napp, Abbott, Cardiac Dimensions, Microport. CL, JV and SR are Medtronic employees. The CRYSTAL AF study and this cost-effectiveness analysis were funded by Medtronic.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"486"}}